Kelly Jared bought ONCY

March 12, 2026 · Form 4 insider transaction

Kelly Jared bought 5,050 shares of Oncolytics Biotech Inc. at $0.96 per share, a transaction worth $4.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.